Cargando…
Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report
BACKGROUND: Metachromatic Leukodystrophy (MLD) is a rare, fatal demyelinating disorder with limited treatment options. Published outcomes after hematopoietic stem cell transplantation (HSCT) are scant and mixed. We report survival and function following HSCT for a large, single-center MLD cohort. ME...
Autores principales: | Boucher, Alexander A., Miller, Weston, Shanley, Ryan, Ziegler, Richard, Lund, Troy, Raymond, Gerald, Orchard, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545855/ https://www.ncbi.nlm.nih.gov/pubmed/26245762 http://dx.doi.org/10.1186/s13023-015-0313-y |
Ejemplares similares
-
Cerebral Spinal Fluid levels of Cytokines are elevated in Patients with Metachromatic Leukodystrophy
por: Thibert, Kathryn A., et al.
Publicado: (2016) -
Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy
por: Al‐Saady, Murtadha, et al.
Publicado: (2023) -
Allogenic hematopoietic stem cell transplantation in two siblings with adult metachromatic leukodystrophy and a systematic literature review
por: Videbæk, Cecilie, et al.
Publicado: (2021) -
Metachromatic leukodystrophy and transplantation: remyelination, no cross‐correction
por: Wolf, Nicole I., et al.
Publicado: (2020) -
Intrathecal baclofen in metachromatic leukodystrophy
por: van der Veldt, Nikki, et al.
Publicado: (2018)